← Leaderboards
Maria S. Salvato
University Of Md Biotechnology Institute
$5,126,188
Attributed
$5,499,678
Total exposure
10
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.2M · FY2005–16$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
Funding mix
By agency
NIH$5,499,678 · 10
By mechanism
R21$2,427,750 · 6
R01$2,087,018 · 3
RC2$984,910 · 1
Top collaborators
- Xiaoping Zhu1 shared
Most similar at University Of Md Biotechnology Institute
Same institution · by research overlap
- George K Lewis$7,695,484
Others in their field
Top investigators on “Tissue /Cell Culture”
- James R Gaines · University Of Hawaii At Manoa$24,999,553
- Jay B Jackson · Johns Hopkins University$22,308,100
- C Ronald Kahn · Joslin Diabetes Center$12,500,002
- George Stamatoyannopoulos · University Of Washington$11,744,799
- Laurie H Glimcher · Dana-Farber Cancer Inst$10,563,992
- Peter Karl Sorger · Massachusetts Institute Of Technology$9,821,548
Research focus
Tissue /Cell CultureImmune ResponseInfectionImmunityImmuneGene ExpressionVaccinesBioterrorism /Chemical WarfareAcquired Immunodeficiency SyndromeMacaca MulattaVirusLymphocyteVaccinationBaseVaccine AntigenNonhuman PrimateCytotoxic T LymphocytePublic Health RelevanceCellular ImmunityLifeDendritic CellsFlow CytometryIncidenceHelper T Lymphocyte
Grant awards (19)
HIV Persistence and Cardiopulmonary Disease$231,000
R21 · FY2016 · HL · contact PI
FcRn-targeted mucosal HIV vaccine$746,981
R01 · FY2015 · AI · contact PI
Protection of vaccine immunity by inhibiting Fas/FasL signaling$492,122
RC2 · FY2010 · CA · contact PI
Protection of vaccine immunity by inhibiting Fas/FasL signaling$492,788
RC2 · FY2009 · CA · contact PI
Recombinant Yellow Fever 17D-Lassa Vaccine$454,956
R01 · FY2009 · AI · contact PI
A Lassa Vaccine in primates with AIDS$225,000
R21 · FY2009 · AI · contact PI
A Lassa Vaccine in primates with AIDS$75,000
R21 · FY2009 · AI · contact PI
A Lassa Vaccine in primates with AIDS$187,500
R21 · FY2008 · AI · contact PI
Dendritic Cell Targeting of Lassa Fever Vaccine$222,750
R21 · FY2005 · AI
Dendritic Cell Targeting of Lassa Fever Vaccine$222,750
R21 · FY2004 · AI
Non-Viral Delivery of DNA Vaccines to the Buccal Mucosa$222,750
R21 · FY2003 · DE
Early Response to Agents Causing Flu Like Symptoms$198,500
R21 · FY2003 · AI
Early Response to Hemorrhagic Fever-Causing Arenaviruses$198,500
R21 · FY2003 · AI
ROLE OF AN ANTIAPOPTOTIC AGENT IN AIDS PROGRESSION$303,789
R01 · FY2002 · AI
Non-Viral Delivery of DNA Vaccines to the Buccal Mucosa$222,750
R21 · FY2002 · DE
Early Response to Agents Causing Flu Like Symptoms$210,625
R21 · FY2002 · AI
Early Response to Hemorrhagic Fever-Causing Arenaviruses$210,625
R21 · FY2002 · AI
ROLE OF AN ANTIAPOPTOTIC AGENT IN AIDS PROGRESSION$294,942
R01 · FY2001 · AI
ROLE OF AN ANTIAPOPTOTIC AGENT IN AIDS PROGRESSION$286,350
R01 · FY2000 · AI